Evidence map›Paper›PMID 35881271›Full record

ArticleJournal of assisted reproduction and genetics2022

Rates of COVID-19 infection among in vitro fertilization patients undergoing treatment at a university reproductive health center.

Armstrong Abigail, Berger Marisa, Lee Victoria, Tandel Megha, Kwan Lorna, Brennan Kathleen, Al-Safi Zain

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of assisted reproduction and genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Armstrong AbigailDepartment of Obstetrics & Gynecology, University of California Los Angeles, Los Angeles, CA, USA.
Berger MarisaDepartment of Obstetrics & Gynecology, University of California Los Angeles, Los Angeles, CA, USA. mberger@mednet.ucla.edu.ORCID http://orcid.org/0000-0002-4401-1727
Lee VictoriaDavid Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Tandel MeghaDepartment of Medicine, Stanford University, Palo Alto, CA, USA.
Kwan LornaDepartment of Urology, University of California Los Angeles, Los Angeles, CA, USA.
Brennan KathleenDepartment of Obstetrics & Gynecology, University of California Los Angeles, Los Angeles, CA, USA.
Al-Safi ZainDepartment of Obstetrics & Gynecology, University of California Los Angeles, Los Angeles, CA, USA.
University of California, Los Angeles · USStanford University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe coronavirus disease 2019 (COVID-19) caused an unprecedented challenge for in-vitro fertilization (IVF) patients. The incidence of COVID-19 infection among this population is a fundamental knowledge gap.

objectiveThe purpose of this study was to determine the rate of COVID-19 infection among IVF patients compared to other gynecologic surgery patients. MATERIALS AND

methodsThis retrospective study evaluated the incidence of COVID-19 infection among patients undergoing IVF, female fertility-related surgeries (FRS) and other gynecologic surgeries at a single academic institution in Los Angeles, California. All patients underwent routine COVID-19 polymerase chain reaction (PCR) screening prior to treatment.

resultA total of 2742 patients underwent asymptomatic COVID-19 screening before a surgical procedure or IVF between March 1, 2020, and April 5, 2021. The rate of COVID-19 infection among patients who underwent preoperative testing for a non-fertility-related gynecologic procedure was 1.74% (28/1612). In comparison, the positive test results for those who underwent either FRS or IVF were 0.56% (1/180) and 0.34% (1/290), respectively, representing 6.70% (2/30) of positive tests for the whole cohort. The infertility patients had a significantly lower positivity rate compared to the other gynecologic patients during preoperative COVID-19 testing (0.43% vs 1.74%, p = 0.03). CONCLUSION(S): Our study demonstrated that there was a significantly lower incidence of COVID-19 infections in infertility patients undergoing IVF or FRS compared to other gynecologic surgery patients. Future studies should evaluate the cost-effectiveness of routine screening in both the gynecology and infertility patient population, especially in the setting of different variant surges and vaccination rates.

Indexed as

COVID-19InfertilityCOVID-19 TestingFemaleFertilization in VitroHumansPregnancyPregnancy RateReproductive HealthRetrospective StudiesUniversitiesCOVID-19GynecologyInfertilitySurgery

Identifiers

PMID35881271
PMCPMC9314538
OpenAlexW4287877168

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.